Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Overseas sales increased in Southeast Asia, Italy, Mexico and other markets, with growth also benefiting from the weaker yen. In Japan, sales of products such as insecticides declined and promotional expenses, personnel costs and other expenses increased, while the company also made active investments in advertising and promotional expenses in Southeast Asia.
Not applicable (no matters to report in the notes on the going concern assumption)
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥77,366 million (YoY +4.8%) |
| Operating profit | ¥2,190 million (YoY -17.2%) |
| Ordinary income | ¥2,262 million (YoY -10.2%) |
| Profit attributable to owners of the parent | ¥1,206 million (YoY -17.5%) |
| Net income per share | ¥73.24 |
| Operating Margin | 2.8% |
| Equity ratio | End of the current fiscal period 39.1% / End of previous period 38.9% |
| Total assets | ¥68,556 million |
| Net assets | ¥29,327 million |
| Cash flows from operating activities | ¥843 million |
| Cash flows from investing activities | ¥-2,876 million |
| Cash flows from financing activities | ¥985 million |
| Cash and cash equivalents at end of period | ¥8,326 million |
| Full-year earnings forecast | Net Sales ¥84,800 million (YoY +9.6%) / Operating profit ¥2,950 million (YoY +34.7%) / Ordinary income ¥2,810 million (YoY +24.1%) / Net income ¥1,630 million (YoY +35.1%) |
| Annual Dividend Forecast | ¥24 → ¥24(0.0%) |
| Payout ratio | Current fiscal year 32.8% / Next-year forecast 24.3% |
| Segment revenue | Segment Japan / Net Sales ¥26,951 million / Year-on-year (%) ¥-4.6 million, Segment Southeast Asia / Net Sales ¥33,690 million / Year-on-year (%) ¥6 million, Segment Europe / Net Sales ¥13,672 million / Year-on-year (%) ¥17.8 million, Segment Other (outside reportable segments) / Net Sales ¥3,052 million / Year-on-year (%) ¥37.7 million |
| Segment profit | Segment Japan / Segment profit ¥-529 million / Year on year against the same period last year Loss narrowed (loss of ¥713 million in the previous year), Segment Southeast Asia / Segment profit ¥1,452 million / Year-on-year (%) ¥-39.1 million, Segment Europe / Segment profit ¥529 million / Year-on-year (%) ¥8.7 million, Segment Other (outside reportable segments) / Segment profit ¥128 million / Year-on-year (%) ¥100 million |
| Regional sales | Region Domestic / Net Sales ¥26,633 million / Year-on-year (%) ¥-3.6 million, Region Overseas expansion / Net Sales ¥50,733 million / Year-on-year (%) ¥9.8 million |
| Depreciation and amortization | ¥1,756 million |
| Impairment loss | No applicable matters |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥12 million, Gain on sale of investment securities ¥29 million / Extraordinary loss Loss on disposal and sale of non-current assets ¥1 million, Impairment Losses on Shares of Affiliates ¥16 million |
| Disclosure regarding the going concern assumption | Not applicable (no matters to report in the notes on the going concern assumption) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 16,490,000 |
| Treasury Shares at Period-End | 10,853 |
| Factors Behind Changes in Business Performance | Overseas sales increased in Southeast Asia, Italy, Mexico and other markets, with growth also benefiting from the weaker yen. In Japan, sales of products such as insecticides declined and promotional expenses, personnel costs and other expenses increased, while the company also made active investments in advertising and promotional expenses in Southeast Asia. |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Overseas sales increased in Southeast Asia, Italy, Mexico and other markets, with growth also benefiting from the weaker yen. In Japan, sales of products such as insecticides declined and promotional expenses, personnel costs and other expenses increased. The company also made active investments in advertising and promotional expenses in Southeast Asia to strengthen its brand.